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ABSTRACT 1 
Background & Aims: Evidence on the association between physical activity and risk of 2 
hepatobiliary cancers is inconclusive. We examined this association in the European Prospective 3 
Investigation into Cancer and Nutrition cohort (EPIC). 4 
Methods: We identified 275 hepatocellular carcinoma (HCC) cases, 93 intrahepatic bile duct 5 
cancers (IHBC), and 164 non-gallbladder extrahepatic bile duct cancers (NGBC) among 467,336 6 
EPIC participants (median follow-up 14.9 years). We estimated cause-specific hazard ratios 7 
(HRs) for total physical activity and vigorous physical activity, performed mediation analysis, and 8 
secondary analyses to assess robustness to confounding (e.g., due to hepatitis virus infection).  9 
Results: In the EPIC cohort, the multivariable-adjusted HR of HCC was 0.55 (95% confidence 10 
intervals (CI) 0.38-0.80) comparing active and inactive individuals. Regarding vigorous physical 11 
activity, for those reporting >2 hours/week compared to those with no vigorous activity, the HR 12 
for HCC was 0.50 (0.33-0.76). Estimates were similar in sensitivity analyses for confounding. 13 
Total and vigorous physical activity were unrelated to IHBC and NGBC. In mediation analysis, 14 
waist circumference explained about 40% and body mass index 30% of the overall association 15 
of total physical activity and HCC.  16 
Conclusions: Findings suggest an inverse association between physical activity and risk of 17 
HCC, which is potentially mediated by obesity. 18 
Lay summary: In a pan-European study of 467,336 men and women, we found that physical 19 
activity is associated with a reduced risk of developing liver cancers over the next decade. This 20 
risk was independent of other liver cancer risk factors, and did not vary by age, gender, smoking 21 
status, body weight, and alcohol consumption. 22 
  23 
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Graphical abstract 1 
> 2 
Highlights 3 
 Liver cancer rates are increasing in Western countries, possibly due to increases in 4 
obesity, diabetes, and physical inactivity. 5 
 Previous evidence was not convincing to support an effect of physical activity on liver 6 
cancer. 7 
 We found that physical activity reduced the risk of hepatocellular carcinoma by about 8 
45%. 9 
 10 
Abbreviations: BMI, body mass index; CI, confidence interval; DNA; deoxyribonucleic acid; 11 
EPIC, European Prospective Investigation into Cancer and Nutrition cohort; EPIC-PAQ, 12 
European Prospective Investigation into Cancer and Nutrition cohort physical activity 13 
questionnaire; g/d, grams per day; HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, 14 
hepatocellular carcinoma; HR, hazard ratio; IHBC, intrahepatic bile duct cancers; MEDLINE, 15 
Medical Literature Analysis and Retrieval System Online; NGBC, non-gallbladder extrahepatic 16 
bile duct cancers; RR, relative risk; SD, standard deviation; US, United States of America; WCRF, 17 
World Cancer Research Fund International.  18 
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Introduction 1 
Liver cancer was the fourth leading cause of cancer death in 2015 [1]. Liver cancer is responsible 2 
for around 47,000 deaths per year in the European Union [2]. Hepatocellular carcinoma (HCC) 3 
is the most common type of primary liver cancer derived from hepatocytes and it accounts for 4 
85-90% of all primary liver cancers worldwide. It is the fifth most common cancer in men and the 5 
seventh most common cancer in women [1]. The distribution of HCC varies greatly according to 6 
geographic location and it is more common in low- and middle-income countries than in 7 
developed countries. HCC more frequently occurs in Asia and Africa than in Europe and the US. 8 
The strongest risk factor for HCC is cirrhosis, a condition that is related to Hepatitis B virus (HBV), 9 
Hepatitis C virus (HCV), excessive consumption of alcohol, and exposure to aflatoxin B1 [1]. The 10 
geographic variability of HCC incidence has been widely associated to the different distribution 11 
of HBV and HCV infections [1, 3]. In high-income countries, the main risk factors for HCC are 12 
smoking, alcoholic cirrhosis, diabetes, obesity, and non-alcoholic hepatic steatosis [1, 4, 5]. The 13 
recent increase in HCC incidence is thought to be caused by increases in obesity, diabetes, and 14 
physical inactivity [6, 7]. The Physical Activity Collaboration of the National Cancer Institute’s 15 
Cohort Consortium performed a pooled analysis of 10 prospective US and European cohorts and 16 
found that high compared to low leisure-time physical activity was associated with a 27% lower 17 
risk of liver cancer incidence [8]. Other prospective studies from the US and East Asian countries 18 
support an association of physical activity and lower risk of hepatobiliary cancers [8-13]. 19 
However, the World Cancer Research Fund International judged that the evidence was not 20 
convincing to support an effect of physical activity on liver cancer [14]. Similarly, an umbrella 21 
review provided limited evidence for an association with liver cancer [15]. We report results from 22 
the EPIC (European Prospective Investigation into Cancer and Nutrition) cohort to provide 23 
additional evidence on the relationship between physical activity and HCC and other 24 
hepatobiliary cancers. 25 
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Methods 1 
Study Population and Data Collection 2 
The EPIC is a multinational prospective cohort study designed to investigate the link between 3 
diet, lifestyle and environmental factors with cancer risk and other chronic diseases. Detailed 4 
information on the study design, rationale, and methods of the EPIC cohort has been described 5 
previously [16]. Briefly, between 1992 and 2000, >520 thousand men and women, aged 25-70 6 
years, were recruited from 23 centers throughout 10 countries (Denmark, France, Germany, 7 
Greece, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom). Data on 8 
physical activity, education, smoking, alcohol consumption, coffee intake, anthropometric 9 
measurements and medical history were collected at baseline, before disease onset or diagnosis. 10 
All cohort members provided written informed consent. Ethics approval was obtained from the 11 
International Agency for Research on Cancer review board (Lyon, France) and participating 12 
centers. A total of 467,336 participants were included in the main analyses for total physical 13 
activity and hepatobiliary cancer risk after the following exclusions: 25,184 participants with 14 
prevalent cancer other than non-melanoma skin cancer; 20 subjects with missing date of 15 
diagnosis; and 4,128 individuals without follow-up. Four EPIC study centers (Naples, Umea, 16 
South-East of Norway, North-West of Norway) did not measure vigorous physical activity. Thus, 17 
the analysis of vigorous physical activity and hepatobiliary cancer risk was limited to 341,533 18 
participants for whom data on this exposure were available. 19 
In a subset [17] of the EPIC cohort as of 2006, sera samples for HBV (ARCHITECT HBsAg, 20 
Abbott Diagnostics, France) and HCV (anti-HCV chemiluminescent microparticle immunoassays, 21 
Abbott Diagnostics, France) serologic tests were available: 115 HCC cases were matched using 22 
incidence density sampling to 230 controls based on age at blood collection, sex, study center, 23 
time of the day at blood collection, fasting status at blood collection; among women, additionally 24 
by menopausal status, and hormone replacement therapy use at time of blood collection. These 25 
data were used in nested case-control analyses to examine potential confounding by viral 26 
hepatitis status for the association of physical activity and HCC.  27 
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Follow-up of Study Population and Case Ascertainment 1 
Incident first primary hepatobiliary cancer cases and vital status were ascertained through record 2 
linkage with cancer and death registries in most centers [16]. In France, Germany and Greece, 3 
ascertainment was done using a combination of methods including health insurance records, 4 
pathology registries and active follow-up through mailed questionnaires/telephone interviews 5 
[16]. Incident cancers were subsequently verified through medical records, pathology reports and 6 
discharge diagnosis [16]. In all centers, cancer diagnosis required confirmation through 7 
comprehensive pathology review [16]. A detailed protocol entitled ‘Guidelines for Collection of 8 
End-point Data in the EPIC study‘ for the collection and standardization of clinical and 9 
pathological data for each cancer site was prepared by a special EPIC working group [16]. 10 
Cancer incidence was coded according to the International Classification of Diseases-Oncology-11 
2. HCC was defined as C22.0. Cancer of the intrahepatic bile duct (IHBC) was defined as C22.1. 12 
Non-gallbladder extrahepatic bile duct tract cancer (NGBC) was defined as tumors in the 13 
extrahepatic bile duct (C24.0), Ampulla of Vater (C24.1) or overlapping lesions of the biliary tract 14 
(C24.8), and the biliary tract not specified (C24.9). We did not consider cancers of the gallbladder 15 
(C23.9) as an endpoint because we assumed different underlying mechanisms [10]. 16 
Assessment of Physical Activity 17 
The validated EPIC physical activity questionnaire (EPIC-PAQ) was used to assess recreational, 18 
household and occupational physical activity during the past year in all EPIC centers, except in 19 
the Norwegian centers [18-20]. Recreational physical activity was assessed by querying about 20 
the amount of time in hours per week during the winter and summer spent with cycling and other 21 
physical exercises (e.g., jogging, swimming) and was summarized into four groups: inactive, 22 
moderately inactive, moderately active, and active [21, 22]. Participants reported their level of 23 
occupational physical activity as either sedentary, standing, manual work or heavy manual work. 24 
They were also asked whether engaging in household and recreational activities had caused 25 
them to experience increases in sweating or heartbeat, and, if so, how many hours per week 26 
they dedicated to these vigorous activities. We derived measures of total physical activity and 27 
vigorous physical activity from the EPIC-PAQ. The Cambridge Index was used as a measure of 28 
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total physical activity by combining recreational physical activity and occupational physical 1 
activity [20, 22]. The Cambridge Index was developed [22] and validated [19] by comparing the 2 
EPIC-PAQ with objective measures of cardiorespiratory fitness and physical activity energy 3 
expenditure. The Spearman correlation between the Cambridge Index and physical activity 4 
energy expenditure was 0.33 (95% confidence interval: 0.28 to 0.38) [19]. The Norwegian EPIC 5 
centers measured total physical activity using a scale that ranged from 1 to 10 [23]; and the 6 
Cambridge Index for the Norwegian centers was derived as described previously [21]. Vigorous 7 
physical activity was categorized into 0, ≤2 (below the median), or >2 (above the median) hours 8 
per week [21, 24]. 9 
Statistical Analysis 10 
Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using cause-specific Cox 11 
proportional hazard models, with age as the underlying time metric. Time of study entry was age 12 
at recruitment and exit time was age at cancer diagnosis or the last date at which follow-up was 13 
considered complete in each center. Models were stratified by center and sex to minimize 14 
departure from proportionality and to control for differences between centers, such as follow-up 15 
procedures and questionnaire design. Trend tests across exposure groups were performed by 16 
modeling the categorical physical activity variables as continuous covariables. We estimated 17 
cumulative incidence functions, adjusted for baseline confounders, accounting for competing risk 18 
of death from causes other than hepatobiliary cancer using a Fine-Gray subdistribution hazard 19 
model. The basic multivariable models were adjusted for education (no school degree, primary 20 
school, technical/professional/secondary, university), smoking status and intensity (never, 21 
current [1 to 15, 16 to 25, or ≥26 cigarettes/day], or former [≤10 or >10 years]; current pipe, cigar 22 
or occasional smoking), current alcohol consumption (grams per day (g/d) modeled continuously 23 
using restricted cubic splines), lifetime alcohol use patterns (never, former, >0 – 6 [men]/> 0 – 3 24 
[women], >6-12 [men]/>3-12 [women], >12-24, >24 – 60, > 60 g/d), and daily number of cups of 25 
coffee (1 cup was defined as 150 mL). For covariates with missing data (see Table 1), multiple 26 
imputation of covariates by fully conditional specification with accommodation of the substantive 27 
model [25] and 25 sets of imputed data was used. We examined multiplicative effect modification 28 
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by testing interaction terms of physical activity variables with sex, age (continuous), waist 1 
circumference (continuous), body mass index (continuous), baseline alcohol consumption 2 
(continuous) and lifetime alcohol consumption (categorical) using likelihood ratio tests; for 3 
continuous covariates a procedure based on fractional polynomials was used [26]. 4 
Because obesity and diabetes may be potential intermediates [4, 27, 28], our primary 5 
multivariable model did not control for them. Causal mediation analysis methods, as described 6 
for survival data [29], were used to examine the proportions of the association of physical activity 7 
with hepatobiliary cancer risk that was mediated by waist circumference, body mass index, and 8 
diabetes. These mediators were selected a priori based on subject knowledge [4, 27, 28] and 9 
were assessed using multiple linear regression (waist circumference, body mass index) and 10 
logistic regression (diabetes) for the mediator models and accelerated failure time models with 11 
Weibull distribution for time to event [29, 30]. Proportion mediated was calculated as indirect 12 
natural effect divided by the sum of the direct and indirect natural effect [29] and 500 simulations 13 
were used to derive quasi-Bayesian CI [30]. To facilitate the interpretation of mediation analyses, 14 
the categories ‘active’ vs. ‘inactive’ of the Cambridge Index and ‘>2 hours/week’ vs. ‘no’ vigorous 15 
physical activity were compared. The mediation method assumes no unmeasured confounding 16 
in the exposure-outcome, mediator-outcome, and exposure-mediator relations, and no effect of 17 
the exposure on confounders of the mediator-outcome relation. We did not detect any exposure-18 
mediator interactions.  19 
We conducted several sensitivity analyses to test the robustness of our primary models. First, to 20 
minimize the influence of reverse causation, we excluded hepatobiliary cancer events that 21 
occurred during the first two years of follow-up. Second, although our primary analysis assumed 22 
that obesity and diabetes mediate the association of physical activity and hepatobiliary cancer 23 
risk, it is also plausible to hypothesize that overweight/obesity and diabetes render physical 24 
activity difficult (i.e., confound the association) [31]. Accordingly, we performed secondary 25 
analyses with additional adjustment for waist circumference and diabetes. Third, we assessed 26 
the robustness of observed associations to unmeasured confounding. Specially, we calculated 27 
E-Values [32], which indicate the minimum strength of association than an unmeasured 28 
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confounder would need to have with the exposure and the outcome on the risk ratio scale to fully 1 
account for an observed exposure-outcome association, above and beyond the measured 2 
covariates. Additionally, we used data from the EPIC nested case-control study [17] to adjust 3 
associations for HBV/HCV status. Odds ratios (OR) for HCC were derived from multivariable 4 
conditional logistic regression, adjusted for matching variables, age, sex, smoking status, current 5 
alcohol use, and coffee intake. Analysis of the nested case-control subset was performed among 6 
all subjects with additional adjustment for HBC/HCV; and among HBC/HCV negative individuals. 7 
Fourth, as an alternative to the stratified Cox model, we modeled unobserved heterogeneity 8 
across centers using a Cox model with a shared frailty. Fifth, due to different assessment of total 9 
physical activity in the Norwegian centers, we re-estimated our Cox models for total physical 10 
activity after excluding data from the Norwegian centers. Sixth, we performed complete cases 11 
analysis when covariates had missing values. P values < 0.05 are reported as statistically 12 
significant. Analyses were performed using R (version 3.5.1), SAS (version 9.4), and Stata 13 
(version 15.1). 14 
Results  15 
EPIC Study 16 
Characteristics of Participants 17 
Among the 467,336 participants in the EPIC study, the mean (SD) age was 51.3 (9.9) years, and 18 
70.2% were women. During a median follow-up time of 14.9 years, participants contributed 19 
6,508,182 person years, and 275 HCC, 93 IHBC, and 164 NGBC cancer cases occurred. Age-20 
adjusted baseline characteristics of the analytical sample are provided in Table 1. 21 
Physical Activity and Hepatobiliary Cancer Risk 22 
Total physical activity and vigorous physical activity were inversely associated with HCC but not 23 
with IHBC and NBGC. The adjusted HR for HCC comparing ‘active’ and ‘inactive’ individuals was 24 
0.55 (95% CI: 0.38 to 0.80, P for Trend < 0.001) (Table 2). The adjusted HR of HCC for ‘>2 25 
hours/week’ of vigorous activity vs. no vigorous activity was 0.50 (95% CI: 0.33 to 0.76, P for 26 
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Trend <0.001) for HCC (Table 3). The adjusted cumulative incidence functions indicate that the 1 
physically inactive group showed excess HCC incidence compared to more active groups (Figure 2 
1). The relations of total physical activity and vigorous physical activity with outcomes were not 3 
modified by sex, age, waist circumference, body mass index, smoking, current alcohol 4 
consumption or lifetime alcohol consumption (all P for interaction >0.1). 5 
Mediation of the Association between Physical Activity and HCC Risk 6 
We used mediation analysis to estimate the proportions of the associations with HCC that were 7 
mediated by waist circumference, body mass index, and diabetes (Table 4). Waist circumference 8 
explained 40% and body mass index 30% of the overall association of total physical activity and 9 
HCC. The proportions of the total effect of vigorous physical activity on HCC mediated by waist 10 
circumference and body mass index were 17% and 12%, respectively. Diabetes did not seem to 11 
mediate the observed associations. 12 
Sensitivity Analyses 13 
In sensitivity analyses, the associations of total physical activity and vigorous physical activity 14 
with HCC, IHBC and NBGC were virtually unchanged when events occurring during the first two 15 
years of follow-up were excluded (Supplementary Tables 1 and 2). In models additionally 16 
adjusted for waist circumference and diabetes, the HR for HCC were attenuated but remained 17 
statistically significant. In the Cox model for total physical activity and HCC, for an unmeasured 18 
confounder to explain the HR estimate of 0.55, the unmeasured confounder would have to 19 
increase the likelihood of physical activity and decrease the likelihood of HCC by 3.0-fold, above 20 
and beyond the measured confounders. For an unmeasured confounder to bring up the upper 21 
confidence limit of 0.80 for this estimate to above 1.0, the unmeasured confounder would still 22 
have to both increase the likelihood of physical activity and decrease the likelihood of HCC by 23 
1.8-fold, conditional on the measured covariates. Similarly, an unobserved confounder would 24 
need to be associated with a RR of 3.4 with vigorous physical activity and HCC to explain the 25 
estimated HR of 0.50 and a RR of 1.9 to move the upper confidence limit above 1.0, conditional 26 
on the measured covariates. We used the EPIC nested case-control study to perform additional 27 
13 
 
adjustment for HBV/HCV. The results of these analyses were similar in direction and magnitude 1 
to those reported for the entire cohort, but they were not statistically significant, due to small 2 
sample size (Supplementary Table 3). However, the data from the case-control dataset provide 3 
further support for the notion that additional confounding by HBV/HCV might not be sufficient to 4 
explain away the observed association of physical activity and HCC. Estimates from frailty 5 
models to account for between-center heterogeneity were similar those from the stratified Cox 6 
models. After exclusion of Norwegian centers and in complete case analyses, HR were almost 7 
identical to the primary analysis. The HR and CI from the complete case analyses were similar 8 
to those from primary models employing multiple imputation (Supplement Tables 1 and 2). 9 
Discussion 10 
In this analysis of a multinational European cohort, higher total physical activity and vigorous 11 
physical activity were associated with lower risk of HCC. We observed a 45% lower risk of HCC 12 
when comparing high and low levels of total physical activity. The highest level of vigorous 13 
physical activity was associated with a 50% lower risk for HCC. Moreover, we observed that 14 
inverse associations of total physical activity and vigorous physical activity with HCC did not differ 15 
substantially between subgroups based on gender, lifestyle, and anthropometric variables. 16 
Findings from the sensitivities analyses suggest that the association of physical activity and HCC 17 
might be robust to reverse causation and unobserved confounding (e.g., by hepatitis virus 18 
infection). Our study also explored the roles of obesity and diabetes in physical activity’s 19 
association with HCC. Our findings indicate that waist circumference mediated about 40% and 20 
BMI about 30% of the overall association of total physical activity and HCC. In contrast, diabetes 21 
did not seem to play an important role as a mediating factor. 22 
These findings are in line with a pooled analysis of 10 cohorts with a total of 1,384 cases that 23 
reported a 27% lower risk of liver cancer comparing high and low levels of leisure time physical 24 
activity [8]. In the NIH-AARP Diet and Health Study, high versus no vigorous physical activity was 25 
related to a 44% lower risk of HCC [10]. Similar to our study, no association between physical 26 
activity and biliary tract cancer was shown in a previous analysis of NIH-AARP Diet and Health 27 
Study [10]. 28 
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Several biological mechanisms might explain the inverse association between physical activity 1 
and hepatobiliary cancer, including systemic and local effects [28, 33]. The interrelated 2 
mechanisms most extensively studied are changes in whole-body and visceral fatness, metabolic 3 
dysregulation (e.g., insulin, glucose, insulin-like growth factors), adipokines (e.g., leptin, 4 
adiponectin), sex hormones (e.g., estrogen, testosterone), chronic low-grade inflammation, 5 
oxidative stress causing DNA damage and gene mutations (e.g., tumor suppression genes), 6 
impaired immune function, diluting effects on carcinogenic bile acids, and decreased intestinal 7 
transit time [33-35]. Evidence from prospective observational studies and randomized controlled 8 
trials suggests that the most relevant mechanism by which physical activity positively affects liver 9 
cancer risk is lowering body weight [27, 36-38]. The present study systematically explored the 10 
role of markers of overall adiposity (BMI), indirect measures of central obesity (waist 11 
circumference) and metabolic dysregulation (diabetes) in the overall association between 12 
physical activity and HCC. We found that central obesity might account for a large proportion of 13 
the direct effect of physical activity on HCC. The mechanisms underlying the association between 14 
central obesity and hepatobiliary cancer, particularly HCC, may occur through accumulation of 15 
excessive liver fat that increases pro-inflammatory molecules, leptin, and adiponectin [27]. 16 
The analysis of this large multinational European cohort provided sufficient events to examine 17 
the association of physical activity with hepatobiliary cancers. The cohort study also provided first 18 
insights into the relative importance of different intensities of physical activity. We performed 19 
sensitivity analyses to address potential selection bias, differences in case ascertainment 20 
between centers, and additional unobserved confounding. Although HBV and HCV are 21 
considered among the strongest risk factors for HCC [3], previous studies [8-13, 37] were unable 22 
to adjust for HBV and HCV. In the EPIC nested case control study the size and direction of the 23 
effect size for the association of physical activity and HCC was similar to that of the entire EPIC 24 
cohort; however, it was not statistically significant. Our sensitivity analyses for unobserved 25 
confounding using E-Values [32] further support the notion that any unmeasured confounding 26 
would need to be substantial to explain the inverse association of physical activity and HCC. The 27 
study had additional limitations. We were not able to adjust for other potentially important 28 
confounding factors (e.g., pleiotropic effects of statins) and to examine the role of intermediate 29 
15 
 
phenotypes (non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, cirrhosis). Further, 1 
compared to the general population, women were overrepresented in our sample, although men 2 
have higher risk of HCC [39]. Another limitation is that we were not able to examine in detail the 3 
type, intensity and amount of physical activity needed to reduce HCC risk. Physical activity and 4 
anthropometric measures were assessed only once at baseline. Repeated measurements of 5 
physical activity, anthropometric measures, and other potential biological intermediates over time 6 
would have strengthen our understanding of the underlying mechanisms. A recent analysis of 7 
the NIH-AARP Diet and Health Study [9] revealed that consistent participation in physical activity 8 
throughout the life course might be needed to reduce the risk of liver cancer incidence. We 9 
performed mediation analysis for indirect effects acting through general and central obesity, but 10 
we were unable to study trajectories of physical activity and body weight that could help to better 11 
separate the role of obesity as a confounder and mediator of the association of physical activity 12 
and risk of hepatobiliary cancer [8].  13 
In conclusion, our analysis suggests that physical activity reduces risk of HCC. Studies with more 14 
detailed and objectively measured physical activity assessed at multiple time points throughout 15 
the life course are warranted to confirm our findings and may help establish the optimal dose, 16 
type, intensity, and timing of physical activity that is needed to prevent HCC.  17 
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Table 1 Age-adjusted Baseline Characteristics of the EPIC Cohort by Total Physical Activity (n = 467,336) 
  
Total physical activity (Cambridge Physical Activity Index) 
 
Total N Inactive Moderately inactive Moderately active Active 
Vigorous Physical Activity (%)      
None 182,178 55.9 42.5 30.0 28.5 
≤2 hours/week 88,245 18.1 19.9 19.0 18.7 
>2 hours/week 71,110 11.2 14.6 17.0 17.1 
Missing 125,803 14.8 23.0 34.0 35.7 
Sex (%)      
Men 139,168 26.8 27.7 27.5 40.4 
Women 328,168 73.2 72.3 72.5 59.6 
Education (%)      
No school degree/ unknown 20,859 7.3 3.7 3.6 4.2 
Primary school 120,284 35.7 23.1 23.1 25.8 
Technical/professional/secondary 198,720 40.0 43.7 43.8 43.6 
University 112,121 15.6 26.3 26.8 24.1 
Missing 10,658 1.3 2.6 2.6 2.3 
Smoking (%)      
Never 20,2567 48.6 43.5 40.9 40.5 
Current      
<15 cigarettes/day 53,680 10.2 11.1 12.1 12.9 
≥15 cigarettes/day 37,534 9.4 7.7 7.4 7.9 
Current pipe, cigar or occasional smoking 40,040 7.3 9.6 9.4 6.8 
Former      
<10 years 44,584 8.2 9.4 9.9 10.8 
≥10 years 75,403 13.6 16.0 16.9 18.4 
Missing 13,528 2.6 2.7 3.4 2.8 
20 
 
Baseline alcohol consumption (g/d)  3.1 5.8 5.4 7.3 
Average Lifetime alcohol consumption (g/d)      
Non-drinkers 28,146 8.7 6.4 4.3 4.6 
Former 17,026 5.1 3.9 2.7 2.9 
>0 – 6 (M)/> 0 – 3 (W) 93,442 25.4 21.3 16.3 17.2 
>6-12(M)/>3-12(W) 110,070 24.6 24.3 22.2 22.6 
>12-24 63,487 12.0 13.4 14.3 14.2 
>24 – 60 41,822 7.2 8.6 10.1 9.8 
>60 8,977 1.5 1.8 2.2 2.2 
Missing 104,366 15.4 20.2 27.8 26.4 
Coffee (ml/d)  179.3 281.1 316.9 409.4 
Waist circumference (cm)  87.2 83.3 82.9 84.2 
Missing 108,439     
Body mass index (kg/m²)      
Missing 82,692 26.4 25.1 24.8 24.9 
Diabetes (%)  5.4 2.6 2.0 1.9 
Missing 36,517     
EPIC, European Prospective Investigation into Cancer and Nutrition. Entries are adjusted medians for continuous variables and adjusted percentages for categorical variables. Adjustment for age using 
median regression (continuous covariates), binary logistic regression (dichotomous covariates), ordinal logistic regression (ordered categorical covariates), multinomial logistic regression (unordered 
categorical covariates)
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Table 2 Association of Total Physical Activity and Hepatocellular Carcinoma (HCC), 
Intrahepatic Bile Duct Cancers (IHBC) and Non-Gallbladder Biliary Tract Cancer 
(NGBC) Risk in the EPIC cohort (n = 467,336) 
 Total Physical Activity (Cambridge Index) P 
Value 
for 
Trend 
 
Inactive  
(Reference) 
Moderately 
inactive Moderately active Active 
HCC (n) 91 83 48 53  
HR (95% CI) 1.00 0.65 (0.48-0.89) 0.49 (0.34-0.71) 0.55 (0.38-0.80) <0.001 
IHBC (n) 26 27 21 19  
HR (95% CI) 1.00 0.72 (0.41-1.26) 0.66 (0.36-1.21) 0.82 (0.43-1.53) 0.477 
NGBC (n) 39 46 36 43  
HR (95% CI) 1.00 0.67 (0.43-1.05) 0.67 (0.42-1.08) 0.88 (0.55-1.39) 0.761 
EPIC, European Prospective Investigation into Cancer and Nutrition. HCC, hepatocellular carcinoma (C22.0). IHBC, intrahepatic 
bile duct cancers (C22.1). Non-gallbladder extrahepatic bile duct tract cancer (NGBC, C24.0, C24.1, C24.8, C24.9). HR (cause-
specific hazard ratio) from center-and sex stratified Cox proportional hazards model, age as time metric, adjusted for education, 
smoking, baseline alcohol consumption, lifetime alcohol consumption, coffee. Missing covariate data was imputed using multiple 
imputation. 
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Table 3 Association of Vigorous Physical Activity and Hepatocellular Carcinoma (HCC), 
Intrahepatic Bile Duct Cancers (IHBC) and Non-Gallbladder Biliary Tract Cancer 
(NGBC) Risk in the EPIC cohort (n = 341,533) 
HR (95% CI) 
Vigorous Physical Activity 
P Value 
for 
Trend 
 None 
(Reference) ≤2 hours/week >2 hours/week  
HCC (n) 122 33 32  
HR (95% CI) 1.00 0.50 (0.33-0.75) 0.50 (0.33-0.76) <0.001 
IHBC (n) 46 11 14  
HR (95% CI) 1.00 0.52 (0.26-1.06) 0.75 (0.39-1.44) 0.271 
NGBC (n) 64 26 24  
HR (95% CI) 1.00 0.78 (0.47- 1.30) 0.80 (0.48-1.35) 0.368 
EPIC, European Prospective Investigation into Cancer and Nutrition. HCC, hepatocellular carcinoma (C22.0). IHBC, intrahepatic 
bile duct cancers (C22.1). Non-gallbladder extrahepatic bile duct tract cancer (NGBC, C24.0, C24.1, C24.8, C24.9). HR (cause-
specific hazard ratio) from center-and sex stratified Cox proportional hazards model, age as time metric, adjusted for education, 
smoking, baseline alcohol consumption, lifetime alcohol consumption, coffee. Missing covariate data was imputed using multiple 
imputation. 
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Table 4 Mediation Analysis for the Association of Total Physical Activity and Vigorous Physical Activity and Hepatocellular Carcinoma (HCC)  
in the EPIC cohort 
 Total Physical Activity (Cambridge Index) 
(n = 363,228) 
Vigorous Physical Activity 
(n = 275,433) 
Mediator Proportion Mediated, % P Value for Indirect Effect 
Proportion 
Mediated, % P Value for Indirect Effect 
Waist Circumference 40.0 0.02 16.7 0.01 
Body Mass Index 29.7 0.02 11.9 <0.01 
Diabetes 4.2 0.21 0.6 0.23 
EPIC, European Prospective Investigation into Cancer and Nutrition. HCC, hepatocellular carcinoma (C22.0). Adjusted for age, sex, education, smoking, baseline alcohol consumption, lifetime alcohol 
consumption, and coffee intake. Complete-case analysis was used for mediation analysis. 
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Figure 1 Cumulative Incidence of HCC according to Total Physical Activity and Vigorous 
Physical Activity 
 
Adjusted cumulative incidence from a Fine-Gray model, with age as time metric, adjusted for education, smoking, baseline 
alcohol consumption, lifetime alcohol consumption, and coffee. 
 
